Crown Bioscience

Compensation

Full Description

Job Summary: The role will be part of a new team within Crown Bioscience, focused exclusively on Top 25 Global Pharma. The individual will be responsible for the development, implementation, and execution of tailored sales strategies in these key accounts to leverage Crown Bioscience's business opportunities in the area of translational science, specifically Oncology. This position is fully remote on the east coast. Responsibilities: •Develop and implement strategic sales plans (short term and long term) to achieve corporate goals in the assigned market; •Identify and analyze business opportunity, and formulate plans to capture the opportunity and deal with problems; •Contact prospective customer/partner companies to further explore business opportunities and manage negotiations; •Develop and maintain key business relationships across a broad sphere of influence, both internally and externally; •Logistics management in daily order. •Flexibility spending up to 40% travel when needed Minimum Requirements: •Bachelor Degree in Molecular and Cell Biology or related life science field. •Drug discovery experience selling to Top 25 Global Pharma – at least 5 years of experience •Relevant business development experience (pharmaceutical, biotech, CRO) is required and proven track record of achieving sales targets •Masterful selling skills and strategic mindset, that result in strong and trusting customer relationships Preferred Requirements: •Advanced degree (Master’s/PhD) preferred; equivalent experience in sales will also be considered •Have strong background in oncology and in vivo pharmacology preferred with at least 8 years in a business development or sales role. •Have a proven track record of selling to Global Top25 Pharma and ability to win complex deals and manage negotiations at all levels, achieving long term value is highly desired The estimated salary if $155,000 to $175,000 based on experience. Crown Bioscience is committed to a diverse and inclusive workplace. Crown Bioscience is an equal opportunity employer and does not discriminate on the basis of race, national origin, gender, gender identity, sexual orientation, protected veteran status, disability, age, or other legally protected status. Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) providing discovery, preclinical, and translational platforms to advance oncology and immuno-oncology. Known for their high quality and expansive in vivo, in vitro, and ex vivo preclinical models, they partner with their clients to quantify the efficacy and pharmacological profile of their drug candidate before they move into the clinic. The company is the only preclinical CRO to provide tumor organoid services utilizing HUB technology and has the world’s largest commercially available PDX collection. Additionally, further services available in the areas of high content imaging and a 3D Ex Vivo Patient Tissue Platform, provide greater insights into complex disease pathophysiology. A range of biomarker analysis and applied genomics services are also available to optimize therapeutic benefit. Crown Bioscience helps to deliver superior drug candidates to ensure that patients get the right treatment at the right time. Founded in 2006, Crown Bioscience has 12 facilities in the US, Europe, and APAC. Find out more: www.crownbio.com Crown Bioscience is committed to a diverse and inclusive workplace. Crown Bioscience is an equal opportunity employer and does not discriminate on the basis of race, national origin, gender, gender identity, sexual orientation, protected veteran status, disability, age, or other legally protected status. If you have a disability or special need that requires accommodation, please let us know: jobs@crownbio.com Headhunters and recruitment agencies may not submit resumes/CVs through this website or directly to managers. Crown Bioscience does not accept unsolicited headhunter and agency resumes. Crown Bioscience will not pay fees to any third-party agency or company that does not have a signed agreement with Crown Bioscience.